{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:19:29Z","timestamp":1782623969018,"version":"3.54.5"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-0509-8-75","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T09:07:18Z","timestamp":1403687238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines"],"prefix":"10.1186","volume":"8","author":[{"given":"Silvia Von","family":"der Heyde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Henjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Korf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Bei\u00dfbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"issue":"21","key":"1340_CR1","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/bioinformatics\/bts514","volume":"28","author":"SM Hill","year":"2012","unstructured":"Hill SM, Lu Y, Molina J, Heiser LM, Spellman PT, Speed TP, Gray JW, Mills GB, Mukherjee S:Bayesian inference of signaling network topology in a cancer cell line. Bioinformatics (Oxford, England). 2012, 28 (21): 2804-2810. PMID: 22923301,","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"12","key":"1340_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/bioinformatics\/bts211","volume":"28","author":"Y Park","year":"2012","unstructured":"Park Y, Bader JS:How networks change with time. Bioinformatics (Oxford, England). 2012, 28 (12): 40-48. PMID: 22689777,","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"2","key":"1340_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/tpj.2010.81","volume":"11","author":"DH Roukos","year":"2011","unstructured":"Roukos DH:Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenom J. 2011, 11 (2): 81-92. PMID: 20975737,","journal-title":"Pharmacogenom J"},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"2005.0010","DOI":"10.1038\/msb4100014","volume":"1","author":"K Oda","year":"2005","unstructured":"Oda K, Matsuoka Y, Funahashi A, Kitano H:A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol. 2005, 1: 2005.0010-PMID: 16729045,","journal-title":"Mol Syst Biol"},{"issue":"21","key":"1340_CR5","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/bts517","volume":"28","author":"A Feiglin","year":"2012","unstructured":"Feiglin A, Hacohen A, Sarusi A, Fisher J, Unger R, Ofran Y:Static network structure can be used to model the phenotypic effects of perturbations in regulatory networks. Bioinformatics (Oxford, England). 2012, 28 (21): 2811-2818. PMID: 22923292,","journal-title":"Bioinformatics (Oxford, England)"},{"key":"1340_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/1471-2105-12-291","volume":"12","author":"C Bender","year":"2011","unstructured":"Bender C, Heyde SV, Henjes F, Wiemann S, Korf U, Beissbarth T:Inferring signalling networks from longitudinal data using sampling based approaches in the r-package \u2018ddepn\u2019. BMC Bioinformatics. 2011, 12: 291-PMID: 21771315,","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"1340_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/bioinformatics\/bts222","volume":"28","author":"CA Penfold","year":"2012","unstructured":"Penfold CA, Buchanan-Wollaston V, Denby KJ, Wild DL:Nonparametric bayesian inference for perturbed and orthologous gene regulatory networks. Bioinformatics. 2012, 28 (12): 233-241. PMID: 22689766,","journal-title":"Bioinformatics"},{"issue":"284","key":"1340_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/scisignal.2003994","volume":"6","author":"JP Wagner","year":"2013","unstructured":"Wagner JP, Wolf-Yadlin A, Sevecka M, Grenier JK, Root DE, Lauffenburger DA, MacBeath G:Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks. Sci Signaling. 2013, 6 (284): 58-","journal-title":"Sci Signaling"},{"key":"1340_CR9","first-page":"PMID: 19156131","volume":"5","author":"WW Chen","year":"2009","unstructured":"Chen WW, Schoeberl B, Jasper PJ, Niepel M, Nielsen UB, Lauffenburger DA, Sorger PK:Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data. Mol Syst Biol. 2009, 5: PMID: 19156131-","journal-title":"Mol Syst Biol"},{"issue":"Pt 2","key":"1340_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/bj20021824","volume":"373","author":"M Hatakeyama","year":"2003","unstructured":"Hatakeyama M, Kimura S, Naka T, Kawasaki T, Yumoto N, Ichikawa M, Kim J-H, Saito K, Saeki M, Shirouzu M, Yokoyama S, Konagaya A:A computational model on the modulation of mitogen-activated protein kinase (MAPK) and akt pathways in heregulin-induced ErbB signalling. Biochem J. 2003, 373 (Pt 2): 451-463. PMID: 12691603,","journal-title":"Biochem J"},{"issue":"7073","key":"1340_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature04177","volume":"439","author":"RB Jones","year":"2006","unstructured":"Jones RB, Gordus A, Krall JA, MacBeath G:A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006, 439 (7073): 168-174. PMID: 16273093,","journal-title":"Nature"},{"issue":"4","key":"1340_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nbt0402-370","volume":"20","author":"B Schoeberl","year":"2002","unstructured":"Schoeberl B, Eichler-Jonsson C, Gilles ED, M\u00fcller G:Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol. 2002, 20 (4): 370-375. PMID: 11923843,","journal-title":"Nat Biotechnol"},{"key":"1340_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-3-1","volume":"3","author":"O Sahin","year":"2009","unstructured":"Sahin O, Fr\u00c3\u0171hlich H, L\u00c3\u0171bke C, Korf U, Burmester S, Majety M, Mattern J, Schupp I, Chaouiya C, Thieffry D, Poustka A, Wiemann S, Beissbarth T, Arlt D:Modeling ERBB receptor-regulated G1\/S transition to find novel targets for de novo trastuzumab resistance. BMC Syst Biol. 2009, 3: 1-PMID: 19118495,","journal-title":"BMC Syst Biol"},{"issue":"8","key":"1340_CR14","doi-asserted-by":"publisher","first-page":"1000438","DOI":"10.1371\/journal.pcbi.1000438","volume":"5","author":"R Samaga","year":"2009","unstructured":"Samaga R, Saez-Rodriguez J, Alexopoulos LG, Sorger PK, Klamt S:The logic of EGFR\/ErbB signaling: theoretical properties and analysis of high-throughput data. PLoS Comput Biol. 2009, 5 (8): 1000438-PMID: 19662154,","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"1340_CR15","doi-asserted-by":"publisher","first-page":"055001","DOI":"10.1088\/1478-3975\/9\/5\/055001","volume":"9","author":"R-S Wang","year":"2012","unstructured":"Wang R-S, Saadatpour A, Albert R:Boolean modeling in systems biology: an overview of methodology and applications. Phys Biol. 2012, 9 (5): 055001-","journal-title":"Phys Biol"},{"issue":"1","key":"1340_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1517\/17530059.2012.718329","volume":"7","author":"JE McDermott","year":"2013","unstructured":"McDermott JE, Wang J, Mitchell H, Webb-Robertson B-J, Hafen R, Ramey J, Rodland KD:Challenges in biomarker discovery: Combining expert insights with statistical analysis of complex omics data. Expert Opin Med Diag. 2013, 7 (1): 37-51. PMID: 23335946,","journal-title":"Expert Opin Med Diag"},{"issue":"18","key":"1340_CR17","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1093\/bioinformatics\/bts363","volume":"28","author":"F Eduati","year":"2012","unstructured":"Eduati F, De Las Rivas J, Di Camillo B, Toffolo G, Saez-Rodriguez J:Integrating literature-constrained and data-driven inference of signalling networks. Bioinformatics (Oxford, England). 2012, 28 (18): 2311-2317. PMID: 22734019,","journal-title":"Bioinformatics (Oxford, England)"},{"key":"1340_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1752-0509-6-133","volume":"6","author":"C Terfve","year":"2012","unstructured":"Terfve C, Cokelaer T, Henriques D, Goncalves E, Morris MK, van Iersel M, Lauffenburger DA, Saez-Rodriguez J, MacNamara A:CellNOptR: a flexible toolkit to train protein signaling networks to data using multiple logic formalisms. BMC Syst Biol. 2012, 6: 133-PMID: 23079107,","journal-title":"BMC Syst Biol"},{"key":"1340_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1751-0473-3-16","volume":"3","author":"I Albert","year":"2008","unstructured":"Albert I, Thakar J, Li S, Zhang R, Albert R:Boolean network simulations for life scientists. Source Code Biol Med. 2008, 3: 16-PMID: 19014577,","journal-title":"Source Code Biol Med"},{"key":"1340_CR20","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2012","unstructured":"R Core Team: R: A Language and Environment for Statistical Computing. 2012, Vienna, Austria: R Foundation for Statistical Computing, R Foundation for Statistical Computing. ISBN 3-900051-07-0. http:\/\/www.r-project.org."},{"issue":"10","key":"1340_CR21","doi-asserted-by":"publisher","first-page":"PMID: 20378558","DOI":"10.1093\/bioinformatics\/btq124","volume":"26","author":"C M\u00fcssel","year":"2010","unstructured":"M\u00fcssel C, Hopfensitz M, Kestler HA:BoolNet\u2013an r package for generation, reconstruction and analysis of boolean networks. Bioinformatics (Oxford, England). 2010, 26 (10): PMID: 20378558-","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"1","key":"1340_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1478-811X-11-43","volume":"11","author":"R Samaga","year":"2013","unstructured":"Samaga R, Klamt S:Modeling approaches for qualitative and semi-quantitative analysis of cellular signaling networks. Cell Commun Signaling: CCS. 2013, 11 (1): 43-PMID: 23803171 PMCID: PMC3698152,","journal-title":"Cell Commun Signaling: CCS"},{"issue":"2","key":"1340_CR23","first-page":"91","volume":"84","author":"AG Gonzalez","year":"2006","unstructured":"Gonzalez AG, Naldi A, S\u00e1nchez L, Thieffry D, Chaouiya C:GINsim: a software suite for the qualitative modelling, simulation and analysis of regulatory networks. Bio Syst. 2006, 84 (2): 91-100. PMID: 16434137,","journal-title":"Bio Syst"},{"key":"1340_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/1471-2105-8-462","volume":"8","author":"A Di Cara","year":"2007","unstructured":"Di Cara A, Garg A, De Micheli G, Xenarios I, Mendoza L:Dynamic simulation of regulatory networks using SQUAD. BMC Bioinformatics. 2007, 8: 462-PMID: 18039375 PMCID: PMC2238325,","journal-title":"BMC Bioinformatics"},{"key":"1340_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1752-0509-3-58","volume":"3","author":"T Helikar","year":"2009","unstructured":"Helikar T, Rogers JA:ChemChains: a platform for simulation and analysis of biochemical networks aimed to laboratory scientists. BMC Syst Biol. 2009, 3: 58-PMID: 19500393 PMCID: PMC2705353,","journal-title":"BMC Syst Biol"},{"key":"1340_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1471-2105-11-233","volume":"11","author":"J Krumsiek","year":"2010","unstructured":"Krumsiek J, P\u00f6sterl S, Wittmann DM, Theis FJ:Odefy\u2013from discrete to continuous models. BMC Bioinformatics. 2010, 11: 233-PMID: 20459647 PMCID: PMC2873544,","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"1340_CR27","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM:Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer. 2010, 127 (12): 2893-2917.","journal-title":"Int J Cancer"},{"issue":"7","key":"1340_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/oncsis.2012.16","volume":"1","author":"F Henjes","year":"2012","unstructured":"Henjes F, Bender C, Heyde SVD, Braun L, Mannsperger HA, Schmidt C, Wiemann S, Hasmann M, Aulmann S, Beissbarth T, Korf U:Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs. Oncogenesis. 2012, 1 (7): 16-","journal-title":"Oncogenesis"},{"issue":"13","key":"1340_CR29","doi-asserted-by":"publisher","first-page":"PMID: 10880430","DOI":"10.1093\/emboj\/19.13.3159","volume":"19","author":"MA Olayioye","year":"2000","unstructured":"Olayioye MA, Neve RM, Lane HA, Hynes NE:The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000, 19 (13): PMID: 10880430-","journal-title":"EMBO J"},{"issue":"3","key":"1340_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.breast.2012.01.009","volume":"21","author":"J Heil","year":"2012","unstructured":"Heil J, Gondos A, Rauch G, Marm\u00e9 F, Rom J, Golatta M, Junkermann H, Sinn P, Aulmann S, Debus J, Hof H, Sch\u00fctz F, Brenner H, Sohn C, Schneeweiss A:Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. Breast (Edinburgh, Scotland). 2012, 21 (3): 303-308. PMID: 22310244,","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"2","key":"1340_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11864-012-0186-4","volume":"13","author":"D Jelovac","year":"2012","unstructured":"Jelovac D, Wolff AC:The adjuvant treatment of HER2-positive breast cancer. Curr Treat Options Oncol. 2012, 13 (2): 230-239. PMID: 22410709,","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"1340_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3816\/CBC.2008.n.047","volume":"8","author":"JW Park","year":"2008","unstructured":"Park JW, Neve RM, Szollosi J, Benz CC:Unraveling the biologic and clinical complexities of HER2. Clin Breast Cancer. 2008, 8 (5): 392-401. PMID: 18952552,","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"1340_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7150\/jca.4925","volume":"4","author":"G Tinoco","year":"2013","unstructured":"Tinoco G, Warsch S, Gl\u00fcck S, Avancha K, Montero AJ:Treating breast cancer in the 21st century: emerging biological therapies. J Cancer. 2013, 4 (2): 117-132. PMID: 23386910,","journal-title":"J Cancer"},{"issue":"1","key":"1340_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1741-7015-10-43","volume":"10","author":"Svd Heyde","year":"2012","unstructured":"Heyde Svd, Beissbarth T:A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer. BMC Medicine. 2012, 10 (1): 43-PMID: 22548923,","journal-title":"BMC Medicine"},{"issue":"11","key":"1340_CR35","first-page":"3151","volume":"62","author":"AB Motoyama","year":"2002","unstructured":"Motoyama AB, Hynes NE, Lane HA:The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Cancer Res. 2002, 62 (11): 3151-3158.","journal-title":"Cancer Res"},{"issue":"7408","key":"1340_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature11249","volume":"487","author":"TR Wilson","year":"2012","unstructured":"Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J:Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature. 2012, 487 (7408): 505-509. PMID: 22763448,","journal-title":"Nature"},{"issue":"8","key":"1340_CR37","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/bjc.2012.85","volume":"106","author":"A Gallardo","year":"2012","unstructured":"Gallardo A, Lerma E, Escuin D, Tibau A, Mu\u00f1oz J, Ojeda B, Barnadas A, Adrover E, S\u00e1nchez-Tejada L, Giner D, Ortiz-Mart\u00ednez F, Peir\u00f3 G:Increased signalling of EGFR and IGF1R, and deregulation of PTEN\/PI3K\/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br J Cancer. 2012, 106 (8): 1367-1373. PMID: 22454081,","journal-title":"Br J Cancer"},{"key":"1340_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/1471-2407-11-248","volume":"11","author":"L Wang","year":"2011","unstructured":"Wang L, Zhang Q, Zhang J, Sun S, Guo H, Jia Z, Wang B, Shao Z, Wang Z, Hu X:PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib. BMC Cancer. 2011, 11: 248-PMID: 21676217,","journal-title":"BMC Cancer"},{"issue":"2","key":"1340_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.yexcr.2004.12.008","volume":"304","author":"S Diermeier","year":"2005","unstructured":"Diermeier S, Horv\u00c3\u0105th G, Knuechel-Clarke R, Hofstaedter F, S\u00f6llosi J, Brockhoff G:Epidermal growth factor receptor coexpression modulates susceptibility to herceptin in HER2\/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp Cell Res. 2005, 304 (2): 604-619. PMID: 15748904,","journal-title":"Exp Cell Res"},{"key":"1340_CR40","volume-title":"Lung cancer (Amsterdam, Netherlands)","author":"AG Pallis","year":"(2013)","unstructured":"Pallis AG, Syrigos KN:Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC. Lung cancer (Amsterdam, Netherlands). (2013), PMID: 23384674,"},{"issue":"15","key":"1340_CR41","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W, National Cancer, Institute of Canada Clinical Trials Group:Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the national cancer institute of canada clinical trials group. J Clin Oncol. 2007, 25 (15): 1960-1966. PMID: 17452677,","journal-title":"J Clin Oncol"},{"issue":"4","key":"1340_CR42","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/pmic.200600757","volume":"7","author":"C Loebke","year":"2007","unstructured":"Loebke C, Sueltmann H, Schmidt C, Henjes F, Wiemann S, Poustka A, Korf U:Infrared-based protein detection arrays for quantitative proteomics. PROTEOMICS. 2007, 7 (4): 558-564.","journal-title":"PROTEOMICS"},{"issue":"2","key":"1340_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/annonc\/mdp304","volume":"21","author":"Y Kataoka","year":"2010","unstructured":"Kataoka Y, Mukohara T, Shimada H, Saijo N, Hirai M, Minami H:Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines. Ann Oncol. 2010, 21 (2): 255-262. PMID: 19633047,","journal-title":"Ann Oncol"},{"issue":"23","key":"1340_CR44","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1158\/0008-5472.CAN-04-3841","volume":"65","author":"R Nahta","year":"2005","unstructured":"Nahta R, Yuan LXH, Zhang B, Kobayashi R, Esteva FJ:Insulin-like growth factor-i receptor\/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Res. 2005, 65 (23): 11118-11128. PMID: 16322262,","journal-title":"Cancer Res"},{"issue":"D1","key":"1340_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/nar\/gkr1122","volume":"40","author":"PV Hornbeck","year":"2011","unstructured":"Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B, Latham V, Sullivan M:PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2011, 40 (D1): 261-270.","journal-title":"Nucleic Acids Res"},{"key":"1340_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2105-10-322","volume":"10","author":"H Fr\u00c3\u0171hlich","year":"2009","unstructured":"Fr\u00c3\u0171hlich H, Sahin O, Arlt D, Bender C, Beissbarth T:Deterministic effects propagation networks for reconstructing protein signaling networks from multiple interventions. BMC Bioinformatics. 2009, 10: 322-PMID: 19814779,","journal-title":"BMC Bioinformatics"},{"issue":"18","key":"1340_CR47","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/bioinformatics\/btq385","volume":"26","author":"C Bender","year":"2010","unstructured":"Bender C, Henjes F, Fr\u00f6hlich H, Wiemann S, Korf U, Beissbarth T:Dynamic deterministic effects propagation networks: learning signalling pathways from longitudinal protein array data. Bioinformatics (Oxford, England). 2010, 26 (18): 596-602. PMID: 20823327,","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"1","key":"1340_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1727","volume":"10","author":"A Almudevar","year":"2011","unstructured":"Almudevar A, McCall MN, McMurray H, Land H:Fitting boolean networks from steady state perturbation data. Stat Appl Genet Mol Biol. 2011, 10 (1): 1-40.","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"4","key":"1340_CR49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","volume":"7","author":"SP Brooks","year":"1998","unstructured":"Brooks SP, Gelman A:General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998, 7 (4): 434-455.","journal-title":"J Comput Graph Stat"},{"issue":"1","key":"1340_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y:Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological). 1995, 57 (1): 289-300. ArticleType: research-article\/Full publication date: 1995\/Copyright \u24b81995 Royal Statistical Society,","journal-title":"J R Stat Soc Series B (Methodological)"},{"issue":"1","key":"1340_CR51","first-page":"PMID: 23110660","volume":"13","author":"MR Odenbrett","year":"2012","unstructured":"Odenbrett MR, Wijs A, Ligtenberg W, Hilbers P, Bo Na Ki, D:Efficient reconstruction of biological networks via transitive reduction on general purpose graphics processors. BMC Bioinformatics. 2012, 13 (1): PMID: 23110660-","journal-title":"BMC Bioinformatics"},{"key":"1340_CR52","doi-asserted-by":"crossref","unstructured":"Mikalsen T, Gerits N, Moens U:Inhibitors of signal transduction protein kinases as targets for cancer therapy. M Raafat El-Gewely (ed.) Biotechnology Annual Review. Elsevier, 153-223. ISBN: 1387-2656 2006. http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1387265606120062.,","DOI":"10.1016\/S1387-2656(06)12006-2"},{"issue":"1","key":"1340_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molonc.2011.11.009","volume":"6","author":"R Dienstmann","year":"2012","unstructured":"Dienstmann R, De Dosso S, Felip E, Tabernero J:Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer. Mol Oncol. 2012, 6 (1): 15-26.","journal-title":"Mol Oncol"},{"issue":"13 Suppl 5","key":"1340_CR54","first-page":"5","volume":"19","author":"FJ Esteva","year":"2005","unstructured":"Esteva FJ, Pusztai L:Optimizing outcomes in HER2-positive breast cancer: the molecular rationale. Oncology (Williston Park, N.Y.). 2005, 19 (13 Suppl 5): 5-16. PMID: 19364051,","journal-title":"Oncology (Williston Park, N.Y.)"},{"issue":"32","key":"1340_CR55","doi-asserted-by":"publisher","first-page":"33759","DOI":"10.1074\/jbc.M402055200","volume":"279","author":"S Sato","year":"2004","unstructured":"Sato S, Fujita N, Tsuruo T:Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK\/MAPK signal transduction pathway. J Biol Chem. 2004, 279 (32): 33759-33767. PMID: 15175348,","journal-title":"J Biol Chem"},{"issue":"15","key":"1340_CR56","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-09-0820","volume":"69","author":"M Maurer","year":"2009","unstructured":"Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, Wu J, Nandula S, Dutta B, Xie Y, Chin YR, Kim D-I, Ferris JS, Gruvberger-Saal SK, Laakso M, Wang X, Memeo L, Rojtman A, Matos T, Yu JS, Cordon-Cardo C, Isola J, Terry MB, Toker A, Mills GB, Zhao JJ, Murty VVVS, Hibshoosh H, Parsons R:3-phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Res. 2009, 69 (15): 6299-6306. PMID: 19602588,","journal-title":"Cancer Res"},{"issue":"5","key":"1340_CR57","doi-asserted-by":"publisher","first-page":"PMID: 16887935","DOI":"10.1124\/mol.106.023911","volume":"70","author":"P-H Tseng","year":"2006","unstructured":"Tseng P-H, Wang Y-C, Weng S-C, Weng J-R, Chen C-S, Brueggemeier RW, Shapiro CL, Chen C-Y, Dunn SE, Pollak M, Chen C-S:Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. Mol Pharmacol. 2006, 70 (5): PMID: 16887935-","journal-title":"Mol Pharmacol"},{"issue":"13","key":"1340_CR58","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-05-3018","volume":"66","author":"F Vega","year":"2006","unstructured":"Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret F-X, Rassidakis GZ:Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 2006, 66 (13): 6589-6597. PMID: 16818631,","journal-title":"Cancer Res"},{"issue":"12","key":"1340_CR59","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1093\/emboj\/19.12.2924","volume":"19","author":"M Fr\u00f6din","year":"2000","unstructured":"Fr\u00f6din M, Jensen CJ, Merienne K, Gammeltoft S:A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J. 2000, 19 (12): 2924-2934. PMID: 10856237,","journal-title":"EMBO J"},{"issue":"4","key":"1340_CR60","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-04-4559","volume":"66","author":"KS Klos","year":"2006","unstructured":"Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D:ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin\/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res. 2006, 66 (4): 2028-2037. PMID: 16489002,","journal-title":"Cancer Res"},{"issue":"3","key":"1340_CR61","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/0008-5472.CAN-06-3493","volume":"67","author":"G Schaefer","year":"2007","unstructured":"Schaefer G, Shao L, Totpal K, Akita RW:Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression. Cancer Res. 2007, 67 (3): 1228-1238. PMID: 17283159,","journal-title":"Cancer Res"},{"key":"1340_CR62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/msb.2009.80","volume":"5","author":"Q Zhong","year":"2009","unstructured":"Zhong Q, Simonis N, Li Q-R, Charloteaux B, Heuze F, Klitgord N, Tam S, Yu H, Venkatesan K, Mou D, Swearingen V, Yildirim MA, Yan H, Dricot A, Szeto D, Lin C, Hao T, Fan C, Milstein S, Dupuy D, Brasseur R, Hill DE, Cusick ME, Vidal M:Edgetic perturbation models of human inherited disorders. Mol Syst Biol. 2009, 5: 321-PMID: 19888216,","journal-title":"Mol Syst Biol"},{"issue":"6","key":"1340_CR63","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1073\/pnas.94.6.2345","volume":"94","author":"TM Connor","year":"1997","unstructured":"Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW, McCurrach ME:bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Nat Acad Sci USA. 1997, 94 (6): 2345-2349. PMID: 9122197,","journal-title":"Proc Nat Acad Sci USA"},{"issue":"2","key":"1340_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","volume":"2","author":"CJ Sherr","year":"2002","unstructured":"Sherr CJ, McCormick F:The RB and p53 pathways in cancer. Cancer Cell. 2002, 2 (2): 103-112. PMID: 12204530,","journal-title":"Cancer Cell"},{"issue":"7","key":"1340_CR65","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/cgt.2008.15","volume":"15","author":"G Sithanandam","year":"2008","unstructured":"Sithanandam G, Anderson LM:The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Therapy. 2008, 15 (7): 413-448. PMID: 18404164,","journal-title":"Cancer Gene Therapy"},{"issue":"1-2","key":"1340_CR66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/emboj\/21.1.72","volume":"21","author":"DK Lynch","year":"2002","unstructured":"Lynch DK, Daly RJ:PKB-mediated negative feedback tightly regulates mitogenic signalling via gab2. EMBO J. 2002, 21 (1-2): 72-82. PMID: 11782427,","journal-title":"EMBO J"},{"issue":"8","key":"1340_CR67","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1073\/pnas.1018001108","volume":"109","author":"A Chakrabarty","year":"2012","unstructured":"Chakrabarty A, S\u00e1nchez V, Kuba MG, Rinehart C, Arteaga CL:Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors. Proc Nat Acad Sci USA. 2012, 109 (8): 2718-2723. PMID: 21368164,","journal-title":"Proc Nat Acad Sci USA"},{"issue":"Pt 2","key":"1340_CR68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1242\/jcs.114.2.257","volume":"114","author":"A Abrieu","year":"2001","unstructured":"Abrieu A, Dor\u00e9e M, Fisher D:The interplay between cyclin-b-cdc2 kinase (MPF) and MAP kinase during maturation of oocytes. J Cell Sci. 2001, 114 (Pt 2): 257-267. PMID: 11148128,","journal-title":"J Cell Sci"},{"issue":"36","key":"1340_CR69","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1038\/sj.onc.1205728","volume":"21","author":"L Jirmanova","year":"2002","unstructured":"Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P:Differential contributions of ERK and PI3-kinase to the regulation of cyclin d1 expression and to the control of the G1\/S transition in mouse embryonic stem cells. Oncogene. 2002, 21 (36): 5515-5528. PMID: 12165850,","journal-title":"Oncogene"},{"issue":"3","key":"1340_CR70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.18632\/oncotarget.130","volume":"1","author":"JS Searle","year":"2010","unstructured":"Searle JS, Li B, Du W:Targeting rb mutant cancers by inactivating TSC2. Oncotarget. 2010, 1 (3): 228-232. PMID: 20706560,","journal-title":"Oncotarget"},{"issue":"11","key":"1340_CR71","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0511342103","volume":"103","author":"H Liu","year":"2006","unstructured":"Liu H, Radisky DC, Nelson CM, Zhang H, Fata JE, Roth RA, Bissell MJ:Mechanism of akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Nat Acad Sci USA. 2006, 103 (11): 4134-4139. PMID: 16537497,","journal-title":"Proc Nat Acad Sci USA"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-8-75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:38:49Z","timestamp":1716856729000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-8-75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-8-75","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]},"assertion":[{"value":"20 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"75"}}